Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinas...
Q2 2026
Aug 4, 2026
Q1 2026
May 5, 2026
FY 2025
Mar 3, 2026
Q4 2025
Q3 2025
Nov 4, 2025